biblically accurate blackmadhi

Discoholic 🪩
Three Goblin Art
he wasn't even looking at me and he found me
Sweet Seals For You, Always

#extradirty
One Nice Bug Per Day
will byers stan first human second
Show & Tell

oozey mess
DEAR READER
"I'm Dorothy Gale from Kansas"

⁂
Claire Keane
Lint Roller? I Barely Know Her
ojovivo

roma★
Not today Justin

Janaina Medeiros
taylor price

izzy's playlists!

seen from China

seen from United States

seen from Malaysia
seen from United Kingdom
seen from United States

seen from United States

seen from Malaysia
seen from United States
seen from United States

seen from Brazil

seen from China
seen from United States

seen from Malaysia
seen from United States

seen from Japan

seen from Türkiye
seen from United States
seen from Switzerland
seen from United States

seen from United States
@enwie
biblically accurate blackmadhi
Franziska 2-4
Franzy... My dear franzy... Love you so much and want you so bad that i feel the need to save you...
𝘛𝘩𝘦 𝘌𝘮𝘱𝘳𝘦𝘴𝘴
ffxiv・Venat ・ ヴェーネス Major Arcana series
[ID in ALT text]
Julian Devorak art dump because if I'm being truly honest with myself I've never fully stopped thinking about him since I was 16
If you hate kids you will NOT fucking change your mind when you have your own. You will have kids you hate taking care of and they will be able to tell. These children are human people and you will fuck them up for the rest of their lives. Don't do that 👍
For millions of people managing type 2 diabetes, mornings begin the same way — a needle, a dose, and a quiet mental note to do it all again
For millions of people managing type 2 diabetes, mornings begin the same way — a needle, a dose, and a quiet mental note to do it all again tomorrow.
That routine just changed.
On March 26, 2026, the U.S. Food and Drug Administration approved Awiqli (insulin icodec-abae), developed by Novo Nordisk, as the first and only once-weekly basal insulin ever approved for adults with type 2 diabetes in the United States.
This is not a minor update to an existing drug.
It is the first entirely new class of basal insulin to reach U.S. patients in more than two decades.
Instead of injecting insulin every single day, people with type 2 diabetes using Awiqli will only need one shot per week, on the same day, every week.
That means reducing from 365 injections a year down to just 52.
For anyone who has ever felt the weight of that daily ritual — the anxiety of forgetting, the physical discomfort, the constant reminder that their body needs help — this approval represents something much bigger than a dosing schedule.
It represents relief.
How the Drug Actually Works
Understanding why this injection lasts a full week requires a quick look inside the body.
Most traditional basal insulins are absorbed into the bloodstream and begin breaking down within 24 hours, which is why patients need a fresh dose every day to maintain stable blood sugar levels.
Awiqli works differently.
Its active ingredient, insulin icodec-abae, is engineered to loosely attach to a blood protein called albumin, which is found naturally and abundantly in the bloodstream.
This attachment creates a slow-release reservoir.
Instead of flooding the system and fading fast, the insulin releases gradually and consistently over an entire seven-day period, keeping blood sugar in a healthy range around the clock...
What Comes Next
Awiqli is not standing alone in this space for long.
Eli Lilly is developing its own once-weekly basal insulin, called efsitora alfa, which is currently in late-stage clinical trials.
If that drug also earns FDA approval, it would give patients and doctors two once-weekly options to choose from, allowing for personalized decisions based on a patient’s health profile, insurance coverage, and individual response.
The broader direction of travel in diabetes care is unmistakable.
Fewer injections, smarter formulations, and better integration with digital tools like continuous glucose monitors and insulin-tracking apps are all converging toward a future where managing diabetes requires less daily mental effort without becoming any less medically precise...
A Small Shot With Large Implications
It is easy to look at a once-weekly injection and see only a scheduling change.
But the science behind Awiqli, the scale of the ONWARDS trials, and the consistent satisfaction reported by patients all point toward something that matters far more than convenience.
Diabetes management has always asked a lot of people.
It asks for daily vigilance, daily discipline, and a daily willingness to confront one’s own condition, sometimes in uncomfortable or inconvenient circumstances.
Anything that reduces that load, without reducing the quality of care, is worth taking seriously.
For the more than 37 million Americans living with diabetes, and the hundreds of millions more around the world, a simpler weekly routine could mean the difference between a treatment plan that works on paper and one that actually works in a person’s life.
That is the real significance of what the FDA approved on March 26, 2026.
Not just a new drug.
A new way of keeping people healthy, one week at a time.
-via Science Aim, March 29, 2026
KH sketchdump
hi. my name is normal about witch hat atelier. here are my one billion doodles
love that fl lures you in with body horror only to stab you in the liver with identity horror. how many of your memories can you lose to the eldritch purple before you're fundamentally a different person? what if you could only escape an oppressive destiny by becoming a fish? are you really human, or are you actually a pile of spiders wearing stolen memories and a very convincing skin-suit? who can say
loved and adored this exchange in my replies on a barduil post. thinking about middle-earth history and what stories survive… ooughh
(thank you @jellitheorange and @vampire-hubby for your thoughts!)
also mayhaps a terra
These types of moments crack me up so much
EVERYONE STOP TELLING ME HOW OLD YOU WERE IN 2008 I DONT WANNA HEAR THAT SHIT
SOME OF YOU SHOULD BE AT THE OPRHANGE
preschool. I meant preschool.
Transphobia is about to be signed into law in the UK. We can fight this.
I am begging the UK trans community and its allies to attend the Mass Lobby at Parliament on June 25th, 11am-4pm, organised by Trans Solidarity Alliance.
Last year we broke the record for an LGBT+ mass lobby of Parliament. Will you help us break it again? Join us on 25th June 2026 to demand be
The new EHRC Code of Practice pushes trans people out of toilets, hospital wards, and community spaces. It normalises gender policing based on appearance and stereotypes. It becomes statutory guidance in the UK by the end of June.
Trans people are now legally their assigned gender at birth and must join gendered spaces accordingly, but if they are perceived as their lived gender, they can also be ejected from those spaces. The guidance says: either break the law, or don’t pass too well.
A mass lobby is where you invite your MP to discuss your concerns with you in-person. Ask your MP to:
Demand full parliamentary scrutiny, debate, and use their free vote on the EHRC Code of Practice.
Support any motions rejecting the EHRC guidance. As of June 4th, Labour MP Nadia Whittome has submitted a prayer motion - Early Day Motion 240.
Write to Bridget Phillipson, the Minister for Women and Equalities about our concerns
Your MP does not have to be an ally, they do not have to respond to your email for you to show up and greencard them (details below the cut.) What matters is that as many people as possible show up.
I cannot stress this enough: Showing up in person matters. It is much more effective than petitions, emails, and letters.
It is a horrible, stressful time, and I am so sorry if you're trans and live in the UK. But I was at last year's mass lobby and the line for greencarding alone stretched around the back gates. It was a record breaking mass lobby and made us impossible to ignore. Let's do even better this time. Details under the cut:
My piece for the Sing O Muse zine! Its coming out in July so keep an eye out for the tag :]